Starting September 2019 Hainsworth will serve as the interface between the EASL Governing Board and the organisation`s Geneva and Brussels operations, ensuring high quality and effective implementation of the Governing Board`s policies and decisions. Hainsworth has worked for 25 years…
GENEVA, Switzerland Last week, ClarivateTM Analytics released the 2019 update of its Journal Citation Reports©, including the much anticipated 2018 impact factor. EASL’s flagship monthly journal, the Journal of Hepatology achieved unprecedented results with a 2018 impact factor of 18.946,…
The General Assembly of the European Association for the Study of the Liver (EASL) has elected new members to its Governing Board, various committees and a new Editor-In-Chief for its Journal of Hepatology. 12 April 2019 - Vienna, Austria The…
According to a study conducted by the EF-Clif published in Gastroenterology This study has shown for the first time that the administration of albumin at high doses has an immunomodulatory effect both in the short (INFECIR-2) and long-term (Pilot-PRECIOSA) in…
Before the advent of antiretroviral drugs, the prognosis for patients with AIDS was extremely poor. However, new antiretroviral treatments have revolutionised care for patients with HIV/AIDS, making lifelong viral suppression possible and improving life expectancy to near normal in patients…
Liver cancer is a leading cause of cancer death, with hepatocellular carcinoma (HCC) accounting for 85–90% of all primary liver cancers. In a recent issue of Journal of Hepatology, Dr Baumeister et al. showed that higher total physical activity was…
SCIENTIFIC PRESS RELEASE Developing personalised targets for treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) Barcelona, Spain - An EU Horizon 2020-financed project investigating methods to better understand the role of the microbiome to help stratify patient health care…
Alcoholic liver disease and nonalcoholic fatty liver disease (NAFLD) are the leading etiologies for chronic liver disease chronic-liver-disease-related deaths in the United States over the last decade, according to the results of a new study. The prevalence of nonalcoholic fatty…
Perspectum Diagnostics released details regarding the latest version of its LiverMultiScan magnetic resonance imaging technology which identified nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, according to a press release. The latest version of LiverMultiScan, known as LiverMultiScan IDEAL, will feature…
As of January 2018 the Specialty Certificate Examination (SCE) in Gastroenterology and the European Section and Board of Gastroenterology and Hepatology Examination (ESBGHE), have been replaced by the European Specialty Examination in Gastroenterology and Hepatology (ESEGH). The ESEGH is a…